Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

Share Price is delayed by 15 minutes
Get Live Data
1,119.00    40.50 (3.76%)
Bid:
1,113.50
Ask:
1,114.50
Spread: 1.00 (0.09%)
Market Cap: £3.59b
PSN Live PriceLast checked at - London Stock Exchange

Intraday Persimmon Share Chart

Director/PDMR Shareholding

31 Mar 2025 15:14

RNS Number : 9789C
Persimmon PLC
31 March 2025
 

 

31 March 2025

Persimmon Plc (the "Company")

 

Director/PDMR Shareholding

 

Persimmon Plc announces that on 28 March 2025 awards were granted to Dean Finch, Group Chief Executive, and Andrew Duxbury, Chief Financial Officer, over 59,854 and 31,122 shares respectively, under the Persimmon Plc 2020 Deferred Bonus Plan. The awards are for the deferred element of the Executive Directors' annual bonus and will ordinarily vest after a three-year period ending on the announcement of the Group's 2027 results.

 

In the case of Andrew Duxbury, this includes the deferred element of his bonus for the buy-out period prior to his joining Persimmon. Further details are included in the Persimmon Directors' Remuneration Report for the year ended 31 December 2024.

 

The below notification, made in accordance with the requirements of the UK Market Abuse Regulation, gives further details:

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

Dean Finch

2

 

Reason for the notification

 

a)

 

Position/status

 

Group Chief Executive

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, UK emission allowance market participant, auction platform or auctioneer

 

a)

 

Name

 

Persimmon Plc

b)

 

LEI

 

213800XI72Y57UWN6F31

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

Transaction 1

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 10p each

Identification code

GB0006825383

b)

 

Nature of the transaction

 

 

Grant of award made under the 2020 Deferred Bonus Plan for the deferred element of Dean Finch's 2025 annual bonus, which will ordinarily vest after a 3-year period ending on the announcement of the Group's 2027 results.

 

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

59,854

 

 

d)

 

Aggregated information

- Aggregated volume

N/A Single transaction

- Price

N/A Single transaction

e)

 

Date of the transaction

 

28 March 2025

f)

Place of the transaction

Outside a trading venue

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

Andrew Duxbury

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Financial Officer

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Persimmon Plc

b)

 

LEI

 

213800XI72Y57UWN6F31

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

Transaction 1

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 10p each

Identification code

GB0006825383

b)

 

Nature of the transaction

 

 

Grant of award made under the 2020 Deferred Bonus Plan for the deferred element of Andrew Duxbury's 2025 annual bonus, which will ordinarily vest after a 3-year period ending on the announcement of the Group's 2027 results.

 

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

31,122

 

 

d)

 

Aggregated information

- Aggregated volume

N/A Single transaction

- Price

N/A Single transaction

e)

 

Date of the transaction

 

28 March 2025

f)

Place of the transaction

Outside a trading venue

 

 

Tracy Davison

Company Secretary

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEALDFDFDSEFA
Date   Source Headline
7th Nov 20197:00 amRNSThird Quarter Trading Statement
1st Nov 201912:18 pmRNSTotal Voting Rights
21st Oct 20193:09 pmRNSBoard Changes
17th Oct 20192:39 pmRNSDirector/PDMR Shareholding
15th Oct 201911:19 amRNSAdditional Listing
1st Oct 20192:37 pmRNSTotal Voting Rights
20th Aug 20198:41 amRNSHalf-year results - Amendment
20th Aug 20197:00 amRNSHalf-year Results
1st Aug 20195:40 pmRNSTotal Voting Rights
4th Jul 20197:00 amRNSTrading Update
11th Jun 20197:18 amRNSDirector/PDMR Shareholding
3rd Jun 20191:53 pmRNSBlock listing Interim Review
3rd Jun 20191:48 pmRNSTotal Voting Rights
23rd May 20191:07 pmRNSAdditional Listing
1st May 20194:22 pmRNSResult of AGM
1st May 201911:23 amRNSTotal Voting Rights
1st May 20197:00 amRNSTrading Update
17th Apr 20197:00 amRNSDirector Appointment
1st Apr 20191:42 pmRNSTotal Voting Rights
21st Mar 20197:00 amRNSCustomer Care Improvement Plan
18th Mar 20192:30 pmRNSAnnual Financial Report
12th Mar 20193:19 pmRNSAdditional Listing
4th Mar 20191:36 pmRNSDirector/PDMR Shareholding
1st Mar 20194:34 pmRNSTotal Voting Rights
26th Feb 20197:00 amRNSCEO Appointment
26th Feb 20197:00 amRNSFinal Results
1st Feb 20194:36 pmRNSTotal Voting Rights
15th Jan 20197:00 amRNSTrading Update
11th Jan 20195:55 pmRNSHolding(s) in Company
2nd Jan 201912:55 pmRNSTotal Voting Rights
11th Dec 201810:18 amRNSDirector/PDMR Shareholding
7th Dec 201812:04 pmRNSDirector/PDMR Shareholding
6th Dec 20184:53 pmRNSDirector/PDMR Shareholding
4th Dec 20183:25 pmRNSBlock listing Interim Review
3rd Dec 20183:50 pmRNSTotal Voting Rights
7th Nov 20187:00 amRNSCEO change
7th Nov 20187:00 amRNSThird Quarter Trading Statement
1st Nov 20184:35 pmRNSTotal Voting Rights
24th Oct 20185:39 pmRNSAdditional Listing
23rd Oct 20185:57 pmRNSEBT Share Purchase
19th Oct 20189:47 amRNSDirector/PDMR Shareholding
15th Oct 20184:08 pmRNSEBT Share Purchase
8th Oct 20184:36 pmRNSHolding(s) in Company
3rd Oct 20183:52 pmRNSEBT Share Purchase
1st Oct 20182:20 pmRNSTotal Voting Rights
19th Sep 201810:31 amRNSEBT Share Purchase
3rd Sep 201810:36 amRNSTotal Voting Rights
21st Aug 20187:00 amRNSHalf Year Results
1st Aug 20181:44 pmRNSTotal Voting Rights
5th Jul 20187:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.